LOGO
LOGO

TODAY'S TOP STORIES

ABT Raises Earnings Forecast, BIIB Provides Rosy Revenue Outlook, ELV Q2 Revenue Up 15.6%

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us
rttnewslogo20mar2024

The following are some of the biotech companies that reported earnings and provided an update on their pipeline yesterday.

1. Abbott Laboratories (ABT), which reported encouraging financial results for the second quarter ended June 30, 2022, has raised its earnings guidance for full year.

On a GAAP basis, net earnings for the second quarter of 2022 climbed to $2.02 billion or $1.14 per share from $1.19 billion or $0.66 per share in the year-ago quarter. Excluding items, net earnings for the second quarter of 2022 were $2.54 billion or $1.43 per share compared to $2.12 billion or $1.17 per share in the second quarter of 2021.

Subscribe to continue reading the article.
This article is available exclusively to RTT Biotech Investor and Intelligent Investor subscribers. Subscribe with a RTTNews subscription.
Start Free Trial
FREE 7-Day Trial - No Payment Required
Already subscribed? Sign in

For comments and feedback contact: editorial@rttnews.com

Business News

Global Economics Weekly Update - Jun 01 - Jun 05, 2026

June 05, 2026 16:18 ET
A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.

Latest Updates on COVID-19